CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...